These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23859101)

  • 1. Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study.
    Sondermeijer BM; Rana JS; Arsenault BJ; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    Eur J Clin Invest; 2013 Oct; 43(10):1009-15. PubMed ID: 23859101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
    van Capelleveen JC; Bochem AE; Boekholdt SM; Mora S; Hoogeveen RC; Ballantyne CM; Ridker PM; Sun W; Barter PJ; Tall AR; Zwinderman AH; Kastelein JJP; Wareham NJ; Khaw KT; Hovingh GK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid assessment, metabolic syndrome and coronary heart disease risk.
    Arsenault BJ; Després JP; Stroes ES; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
    Eur J Clin Invest; 2010 Dec; 40(12):1081-93. PubMed ID: 20701625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of non-HDL cholesterol in risk stratification for coronary artery disease.
    Rana JS; Boekholdt SM; Kastelein JJ; Shah PK
    Curr Atheroscler Rep; 2012 Apr; 14(2):130-4. PubMed ID: 22203405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
    van der Steeg WA; Boekholdt SM; Stein EA; El-Harchaoui K; Stroes ES; Sandhu MS; Wareham NJ; Jukema JW; Luben R; Zwinderman AH; Kastelein JJ; Khaw KT
    Ann Intern Med; 2007 May; 146(9):640-8. PubMed ID: 17470832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major lipids, apolipoproteins, and risk of vascular disease.
    ; Di Angelantonio E; Sarwar N; Perry P; Kaptoge S; Ray KK; Thompson A; Wood AM; Lewington S; Sattar N; Packard CJ; Collins R; Thompson SG; Danesh J
    JAMA; 2009 Nov; 302(18):1993-2000. PubMed ID: 19903920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years.
    Simons LA; Simons J; Friedlander Y; McCallum J
    Atherosclerosis; 2001 Nov; 159(1):201-8. PubMed ID: 11689222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
    Rana JS; Visser ME; Arsenault BJ; Després JP; Stroes ES; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    Int J Cardiol; 2010 Sep; 143(3):399-404. PubMed ID: 19394708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
    Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
    Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Cohn SD; Schaefer MM; Ordovas JM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):779-92. PubMed ID: 8071601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels.
    Ohta T; Saku K; Nakamura R; Maung KK; Matsuda I
    Atherosclerosis; 1998 Apr; 137(2):321-8. PubMed ID: 9622275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
    Manfroi WC; Zago AJ; Campos M; Alves A; Brisolara ML; de Souza J; Candiago RH; Kirschnick L; Ribeiro L; Ordovás K; Leitão C; Cruz R
    Arq Bras Cardiol; 1999 Jun; 72(6):657-68. PubMed ID: 10752172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men.
    Skretteberg PT; Grundvold I; Kjeldsen SE; Erikssen JE; Sandvik L; Liestøl K; Erikssen G; Pedersen TR; Bodegard J
    Atherosclerosis; 2012 Jan; 220(1):250-6. PubMed ID: 22062589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis.
    Su X; Cai X; Pan Y; Sun J; Jing J; Wang M; Meng X; Wang Y; Wei T; He Y
    Eur J Prev Cardiol; 2022 Dec; 29(18):2349-2358. PubMed ID: 36166398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.